Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06319534
What this trial is testing

Stellate Ganglion Block in Bulbar Palsy

Who this might be right for
Bulbar Palsy
Zeng Xi 124
Not applicableWithdrawnNCT05830214
What this trial is testing

Digital Smartwatch Measurements as Potential Biomarkers for Remote Disease Tracking in ALS

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisMuscular Atrophy, Progressive+2 more
University of Alberta
Not applicableNo Longer AvailableNCT04309604
What this trial is testing

IC14 for ALS Patients Expanded Access

Who this might be right for
Amyotrophic Lateral Sclerosis
Implicit Bioscience
Not applicableActive Not RecruitingNCT03421977
What this trial is testing

Long-Term Follow-up Study for Patients From AVXS-101-CL-101

Who this might be right for
Spinal Muscular Atrophy 1
Novartis Gene Therapies 13
Not applicableStudy completedNCT02156141
What this trial is testing

High Intensity Training in Patients With Spinal and Bulbar Muscular Atrophy

Who this might be right for
Spinal and Bulbar Muscular AtrophyHealthy Subjects
Karen Brorup Heje Pedersen 10
Large-scale testing (Phase 3)Study completedNCT00876772
What this trial is testing

Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Charite University, Berlin, Germany 40
Not applicableUnknownNCT04918251
What this trial is testing

EEG and TMS-based Biomarkers of ALS, MS and FTD

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaMultiple Sclerosis
University of Dublin, Trinity College 400
Testing effectiveness (Phase 2)Study completedNCT02794857
What this trial is testing

Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 138
Not applicableUnknownNCT04328675
What this trial is testing

Registration Study of Amyotrophic Lateral Sclerosis (ALS) in Mainland China

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 4,752
Testing effectiveness (Phase 2)UnknownNCT01494480
What this trial is testing

The Clinical Trial on the Use of Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
General Hospital of Chinese Armed Police Forces 30
Not applicableApproved For MarketingNCT03955679
What this trial is testing

AveXis Managed Access Program Cohort for Access to AVXS-101

Who this might be right for
Spinal Muscular Atrophy
United BioSource, LLC
Large-scale testing (Phase 3)Ended earlyNCT05442775
What this trial is testing

A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 71
Testing effectiveness (Phase 2)Study completedNCT04313166
What this trial is testing

Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

Who this might be right for
Amyotrophic Lateral Sclerosis
Collaborative Medicinal Development Pty Limited 55
Post-approval studies (Phase 4)Looking for participantsNCT05923905
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients

Who this might be right for
Sporadic and Familial Amyotrophic Lateral Sclerosis
Peking University Third Hospital 64
Not applicableActive Not RecruitingNCT06834269
What this trial is testing

Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Campus Bio-Medico University 60
Not applicableActive Not RecruitingNCT05095571
What this trial is testing

A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study

Who this might be right for
Amyotrophic Lateral Sclerosis
Haukeland University Hospital 300
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableStudy completedNCT06165172
What this trial is testing

Early Feasibility Study of the MyoRegulator® for Treatment of ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 5
Large-scale testing (Phase 3)Study completedNCT01285583
What this trial is testing

Safety Extension Study of TRO19622 in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Hoffmann-La Roche 271
Testing effectiveness (Phase 2)Study completedNCT03204500
What this trial is testing

Dual Treatment With Lithium and Valproate in ALS.

Who this might be right for
Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis, Sporadic
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez 43
Next Page